Down‐regulation of muscarinic receptors and the m3 subtype in white‐footed mice by dietary exposure to parathion
- 1 July 1993
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 39 (3) , 395-415
- https://doi.org/10.1080/15287399309531760
Abstract
The effect of ad libitum dietary exposure (as occurs in the field) to parathion for 14 d was investigated on the muscarinic acetylcholine receptor (mAChR) in brains and submaxillary glands of adults of a field species, the white‐footed mouse Peromyscus leucopus. Immunoprecipitation using subtype selective antibodies revealed that the relative ratios of the m1‐m5 mAChR subtypes in Peromyscus brain were similar to those in rat brain. There was little variability in acetylcholinesterase (AChE) activity in control mice brains but large variability in 39 exposed mice, resulting from differences in food ingestion and parathion metabolism. Accordingly, data on radioligand binding to mAChRs in each mouse brain were correlated with brain AChE activity in the same mouse, and AChE inhibition served as a biomarker of exposure reflecting in situ paraoxon concentrations. Exposure to parathion for 14 d reduced maximal binding (Bmax) of [3H]quinuclidinyl benzilate ([3H]QNB), [3H]‐N‐methylscopolamine ([3H]NMS), and [3H]‐4‐diphenylacetoxy‐N‐methylpiperidine methiodide ([3H]‐4‐DAMP) by up to ∼58% without affecting receptor affinities for these ligands. Maximal reduction in Bmax of [3H]QNB and [3H]‐4‐DAMP binding occurred in mice with highest AChE inhibition, while equivalent maximal reduction in Bmax of [3H]NMS occurred in mice with only ∼10% AChE inhibition, without further change at higher parathion doses. This is believed to be due to the hydrophilicity of [3H]NMS, which limits its accessibility to internalized desensitized receptors. In submaxillary glands (mAChRs are predominantly m3 subtype), there were significant dose‐dependent reductions in [3H]QNB binding and m3 mRNA levels in exposed mice, revealed by Northern blot analyses. The reduction in m3 receptors is suggested to result mostly from reduced synthesis at the transcription level, rather than from translational or posttranslational events. The data suggest that down‐regulation of mAChRs occurs after dietary exposure (or 14 d to sublethal concentrations of parathion in a field rodent species, and that significant though incomplete recovery in AChE and mAChRs occurs in 7 d following termination of exposure.Keywords
This publication has 41 references indexed in Scilit:
- Subacute reserpine treatment reveals preferential coupling between the M3 muscarinic receptor subtype and phosphatidylinositol turnoverLife Sciences, 1992
- DFP-induced regulation of cardiac muscarinic receptor mRNA in vivo measured by DNA-excess solution hybridizationLife Sciences, 1991
- The presence of an M4 subtype muscarinic receptor in the bovine adrenal medulla revealed by mRNA and receptor binding analysesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Agonist‐induced down‐regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell lineFEBS Letters, 1990
- Molecular Mechanisms of Regulation of Neuronal Muscarinic Receptor SensitivityMembrane Biochemistry, 1990
- Brain acetylcholinesterase activity recovery following acute methyl parathion intoxication in two feral rodent species: Comparison to laboratory rodentsBulletin of Environmental Contamination and Toxicology, 1988
- Changes in affinity states during down‐regulation of muscarinic receptors in tracheal smooth muscle of organophosphate‐treated swineJournal of Autonomic Pharmacology, 1988
- Temporal patterns of brain cholinesterase activities of white-footed mice (Peromyscus leucopus) following dosing with diazinon or parathionArchives of Environmental Contamination and Toxicology, 1985
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983
- Muscarinic receptor alterations as a mechanism of anticholinesterase toleranceToxicology and Applied Pharmacology, 1983